English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [531]
News [1950]
Articles [133]
Editorials [6]
Conferences [60]
elearning [17]
Study on anal cancer supports the current standard of care
Study on anal cancer supports the current standard of care
Oxaliplatin does not improve outcomes for rectal cancer
Oxaliplatin does not improve outcomes for rectal cancer
Genetic testing for breast or ovarian cancer risk not incorporated into clinical practice
Genetic testing for breast or ovarian cancer risk not incorporated into clinical practice
Avastin (bevacizumab) increases risk of hole in stomach and bowels
Avastin (bevacizumab) increases risk of hole in stomach and bowels
CRUK and GSK trial new aurora kinase inhibitor
CRUK and GSK trial new aurora kinase inhibitor
New drug reduces chemotherapy nausea
New drug reduces chemotherapy nausea
Androgen-receptor: a new drug target in breast cancer
Androgen-receptor: a new drug target in breast cancer
Gene signature identifies patients who will respond to chemo
Gene signature identifies patients who will respond to chemo
Pilot study utilises molecular profiling to find potential targets and select treatments for refractory cancers
Pilot study utilises molecular profiling to find potential targets and select treatments for refract...
Mutations impair response to EGFR-targeted therapies in metastatic colorectal cancer
Mutations impair response to EGFR-targeted therapies in metastatic colorectal cancer
<1...188189190191192...195>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307